Domov › Rak dojke › North Carolina › Durham
Klinične študije za Rak dojke v Durham, NC
64 študij za Rak dojke išče udeležence na lokacijah v Durham in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
A Study of PHST001 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Vključevanje udeležencevFaza 3
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
- University of North Carolina, Chapel Hill · 10 mi stran
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Vključevanje udeležencevFaza 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
Vključevanje udeležencevOpazovalna študija
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- University of North Carolina, Chapel Hill · 10 mi stran
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Vključevanje udeležencevFaza 2
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Vključevanje udeležencevFaza 3
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Vključevanje udeležencevFaza 1
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- University of North Carolina Medical Center, Chapel Hill · 10 mi stran
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Vključevanje udeležencevFaza 2
- University of North Carolina Medical Center, Chapel Hill · 10 mi stran
Identifying Patterns in the Breath of Individuals With Breast Cancer
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Vključevanje udeležencevFaza 2
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi stran
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Vključevanje udeležencevFaza 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi stran
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Vključevanje udeležencevFaza 3
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
Vključevanje udeležencevOpazovalna študija
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Vključevanje udeležencevFaza 1/2
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Vključevanje udeležencevFaza 1
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Vključevanje udeležencevFaza 1/2
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Vključevanje udeležencevFaza 3
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
Vključevanje udeležencevFaza 2
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
Vključevanje udeležencevFaza 2
- University of North Carolina, Chapel Hill · 10 mi stran
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Vključevanje udeležencevFaza 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mi stran
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Vključevanje udeležencevFaza 2
- University of North Carolina, Chapel Hill · 10 mi stran
Optimizing Surgical Decisions in Young Adults With Breast Cancer
Vključevanje udeležencev
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
Vključevanje udeležencevOpazovalna študija
- University of North Carolina, Chapel Hill · 10 mi stran
Weight Management After Cancer for Survivors in Rural Communities
Vključevanje udeležencev
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
Vključevanje udeležencev
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Vključevanje udeležencevFaza 2/3
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Vključevanje udeležencev
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Vključevanje udeležencevFaza 2
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
Vključevanje udeležencev
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
Vključevanje udeležencevFaza 1
- University of North Carolina, Chapel Hill · 10 mi stran
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Vključevanje udeležencev
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mi stran
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Vključevanje udeležencev
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
Vključevanje udeležencevOpazovalna študija
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi stran
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Vključevanje udeležencevFaza 3
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
Vključevanje udeležencevFaza 1
- University of North Carolina, Chapel Hill · 10 mi stran
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
- The University of North Carolina, Chapel Hill · 10 mi stran
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
Vključevanje udeležencevOpazovalna študija
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
Vključevanje udeležencevFaza 2
- University of North Carolina, Chapel Hill · 10 mi stran
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
Vključevanje udeležencev
- University of North Carolina, Chapel Hill · 10 mi stran
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Vključevanje udeležencevFaza 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi stran
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Vključevanje udeležencevFaza 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
Vključevanje udeležencevFaza 2
- University of North Carolina, Chapel Hill · 10 mi stran
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
Vključevanje udeležencevFaza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Vključevanje udeležencev
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Vključevanje udeležencevFaza 1/2
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Vključevanje udeležencevOpazovalna študija
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Vključevanje udeležencevFaza 2
- University of North Carolina, Chapel Hill · 10 mi stran
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Vključevanje udeležencevFaza 1
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
Vključevanje udeležencev
- UNC Cancer Hospital, Chapel Hill · 10 mi stran
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
Vključevanje udeležencev
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Vključevanje udeležencev
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
Vključevanje udeležencev
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
BREAST Choice Decision Tool R21 - AIM2
Vključevanje udeležencevVabljeni zdravi prostovoljci
- The University of North Carolina, Chapel Hill · 10 mi stran
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Vključevanje udeležencev
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi stran
UNC Pleural Fluid Registry
Vključevanje udeležencevOpazovalna študija
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Študije za Rak dojke v drugih mestih
- New York City, NY136 študij
- Houston, TX126 študij
- Boston, MA112 študij
- Nashville, TN81 študij
- Los Angeles, CA73 študij
- Edison, NJ68 študij
- St. Louis, MO64 študij
- Queens, NY64 študij
- Chicago, IL59 študij
- Philadelphia, PA56 študij
- Dallas, TX55 študij
- Arlington, VA47 študij
Druge študije v Durham
- Rak (vse vrste)58 študij
- Nemalicelični pljučni rak39 študij
- Množni mielom37 študij
- Akutna mieločna levkemija33 študij
- Metastatski rak33 študij
- Rak prostate32 študij
- Rak pljuč32 študij
- Kolorektalni rak28 študij
- Rak jajčnikov27 študij
- Kronična limfocitna levkemija27 študij
- Srčno popuščanje26 študij
- Rak trebušne slinavke24 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.